Inhibitory effects of galectin-3 on the inflammatory cytokines and chemokines in guinea pig asthma models

Journal of Sichuan University (Medical Science)

Volumn 36, Issue 3, 2005, Pages 355-358

  Li, Lian ^a   Liu, Chun Tao ^a   Wang, Ke ^a   Pang, Ya Min ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Asthma; Eosinophils; Eotaxin; Galectin 3; Interleukin 5

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CCR3; CYTOKINE; DEXAMETHASONE; EOTAXIN; GALECTIN 3; INTERLEUKIN 5; INTERLEUKIN 5 ANTIBODY; MESSENGER RNA; OVALBUMIN; POLYCLONAL ANTIBODY; SODIUM CHLORIDE;

AEROSOL; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BONE MARROW; CONTROLLED STUDY; EOSINOPHIL; GUINEA PIG; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LUNG PARENCHYMA; NONHUMAN; RNA TRANSCRIPTION; SENSITIZATION;

EID: 19744371830     PISSN: 1672173X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Broide D, Sriramarao P. Eosinophil trafficking to sites of allergic inflammation. Immunol Rev, 2001;179:163.
2. Lilly CM, Nakamura H, Belostotsky OI, et al. Eotaxin expression after segmental allergen challenge in subjects with atopic asthma. Am J Respir Crit Care Med, 2001;163(7):1669.
3. Victoria del Pozo, Marta Rojo, Maria L. Rubio, et al. Gene therapy with gelectin-3 inhibits bronchial obstruction and inflammation in antigen-challenged rats through interleukin-5 gene downregulation. Am J Respir Crit Care Med, 2002;166: 732.
4. Gonzalo JA, Lloyd CM, Wen D, et al. The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness. J Exp Med, 1998;188(1):157.
5. Ying S, meng Q, Zeibecoglou K, et al. C-C chemokines and CCR-3 in asthma. J Immunol, 1999;163(11):6321.
6. Banwell ME, Tolley NS, Williams TJ, et al. Regulation of human eotaxin-3/CCL26 expression, modulation by cytokines and glucocorticoids. Cytokine, 2002;17(6):317.
7. Mattoli S, Stacey MA, Sun G, et al. Eotaxin expression and eosinophilic inflammation in asthma. Biochem Biophys Res Commun, 1997;236(2):299.
8. Brown JR, Kleimberg J, Marini M, et al. Kinetics of eotaxin expression and its relationship to eosinophil accumulation and activation in bronchial biopsies and bronchoalveolar lavage (BAL) of asthmatic patients after allergen inhalation. Clin Exp Imuunol, 1998;114(2):137.
9. Uings I, McKinnon M. Development of IL-5 Receptor Antagonists. Curr Pharm Des, 2002;8(20):1837.
10. Schedvins P, Hjelmstrom P. Chemokines a hope of specific antiinflammatory treatment. Lakartidningen, 2002;99(10):1056.
11. Liu FT, Hsu DK, Zuberi RI, et al. Modulation of functional properties of Galectin-3 by monoclonal antibodies binding to the non-lectin domains. Biochemistry, 1996;35(19):6073.